[1]Wang Z, Guo E, Yang B, et al. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer[J]. Gynecol Oncol, 2021, 163:358-363. [2]Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 1:1-9. [3]Ali MAM. DEAD-box RNA helicases: The driving forces behind RNA metabolism at the crossroad of viral replication and antiviral innate immunity[J]. Virus Res, 2021, 296:198352. doi: 10.1016/j.virusres.2021.198352. [4]Nyamao RM, Wu J, Yu L, et al. Roles of DDX5 in the tumorigenesis, proliferation, differentiation, metastasis and pathway regulation of human malignancies[J]. Biochim Biophys Acta Rev Cancer, 2019, 1871:85-98. [5]Xue Y, Jia X, Li C, et al. DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity[J]. Cell Death Dis, 2019, 10:814-825. [6]Wu KJ. The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness[J]. Biomed J, 2020, 43:107-114. [7]姚莎莎,尚文雯,徐睿,等. 沉默PDK1基因抑制卵巢癌细胞系SKOV3的增殖及侵袭[J]. 基础医学与临床, 2019, 39: 1381-1387. [8]Wills B, Fan Q, Alexander C, et al. Confusion following treatment of ovarian cancer[J]. Am J Med, 2019, 132: e610-e611. [9]Luo Q, Que T, Luo H, et al. Upregulation of DEAD box helicase 5 and 17 are correlated with the progression and poor prognosis in gliomas[J]. Pathol Res Pract, 2020, 216:152828. doi: 10.1016/j.prp.2020.152828. [10]郭菲菲,康岚. Ddx5和Ddx17在肿瘤中的表达调控及意义[J]. 中国科技论文在线精品论文, 2018, 11:862-870. [11]Zhou HZ, Li F, Cheng ST, et al. DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis[J]. Hepatology, 2022, 75:847-865. [12]Wortham NC, Ahamed E, Nicol SM, et al. The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer[J]. Oncogene, 2009, 28:4053-4064. [13]Giraud G, Terrone S, Bourgeois CF. Functions of DEAD box RNA helicases DDX5 and DDX17 in chromatin organization and transcriptional regulation[J]. BMB Rep, 2018, 51:613-622. [14]Cui Y, Hunt A, Li Z, et al. Lead DEAD/H box helicase biomarkers with the therapeutic potential identified by integrated bioinformatic approaches in lung cancer[J]. Comput Struct Biotechnol J, 2020, 19:261-278. [15]Zhang L, Li X. DEAD-box RNA helicases in cell cycle control and clinical therapy[J]. Cells, 2021, 10:1540-1560. [16]Xu K, Sun S, Yan M, et al. DDX5 and DDX17-multifaceted proteins in the regulation of tumorigenesis and tumor progression[J]. Front Oncol, 2022, 12:943032.doi: 10.3389/fonc.2022.943032. |